What is BLBD's health score?

Blue Bird Corp (BLBD) has a TradeApes health score of 74 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BLBD's estimated fair value?

Based on our 5-year discounted cash flow model, Blue Bird Corp's estimated fair value is $21.76 per share, representing a -69.8% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BLBD undervalued or overvalued?

Our model currently rates BLBD as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BLBD... Refresh in a moment for the full analysis.

Blue Bird Corp (BLBD)

Consumer Cyclical Overvalued low healthy

$71.95

Updated: 2026-06-05

TradeApes Score

Financial Strength

90 Strong

Operating Trend

78 Strong

Relative Value

55 Mixed

Capital Allocation

70 Healthy

Risk

80 Strong

Est. Fair Value $21.76

DCF Upside -69.8%

Sector Rank #140 of 3113

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Above historical median — trading above its own valuation average

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.